1101 Mrv0541 02231215142D 25 26 0 0 1 0 999 V2000 5.9370 -0.0354 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 5.1754 -2.9954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0559 -2.7404 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.6105 -4.4474 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -1.6854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 2.0272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.7896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 -1.6854 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.4479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 0.7896 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.8405 -2.9954 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 4.0955 -3.7800 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.5080 -2.5104 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.9205 -3.7800 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 5.4054 -4.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 -1.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -1.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 -0.4479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 -0.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 3.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 3.2647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 4.5022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 2.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.2021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 4.9147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 18 1 0 0 0 0 2 13 1 0 0 0 0 2 14 1 0 0 0 0 11 3 1 1 0 0 0 12 4 1 1 0 0 0 5 17 2 0 0 0 0 6 23 1 0 0 0 0 6 24 1 0 0 0 0 7 24 2 0 0 0 0 13 8 1 6 0 0 0 8 16 1 0 0 0 0 8 17 1 0 0 0 0 9 17 1 0 0 0 0 9 19 2 0 0 0 0 10 19 1 0 0 0 0 10 24 1 0 0 0 0 11 12 1 0 0 0 0 11 13 1 0 0 0 0 12 14 1 0 0 0 0 14 15 1 6 0 0 0 16 18 2 0 0 0 0 18 19 1 0 0 0 0 20 21 1 0 0 0 0 20 22 1 0 0 0 0 21 23 1 0 0 0 0 22 25 1 0 0 0 0 M END > DB01101 > drugbank > CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O > InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1 > GAGWJHPBXLXJQN-UORFTKCHSA-N > C15H22FN3O6 > 359.3501 > 359.149263656 > 6 > 47 > -0.02311135068885848 > 35.93609197046743 > 1 > 3 > 0 > 1 > pentyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate > 1.17 > 0.7680360469999987 > -3.16 > 0 > 0 > 2 > 0 > 12.58846629011208 > 8.626069347893116 > 0.07348816553113491 > 120.69 > 82.746 > 7 > 1 > 2.48e-01 g/l > biotin > 0 > DB01101 > APRD00203 > approved; investigational > Capecitabine > (1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester; Capecitabin; Capecitabina; Capécitabine; Capecitabine; Capecitabinum; Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate; pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate > Ach-capecitabine; Apo-capecitabine; Capecitabine; Capecitabine 150mg; Capecitabine 500mg; Capecitabine Accord; Capecitabine Medac; Capecitabine Sun; Capecitabine Tablets, 150 mg; Capecitabine Tablets, 500 mg; Capecitabine Teva; Ecansya; Mint-capecitabine; Sandoz Capecitabine; Taro-capecitabine; Teva-capecitabine; Xeloda $$$$